Low Threshold to Consider DVA With Advanced BTA Disease

Speaker(s)

• 

  Daniel Clair, MD

  Chair, Department of Vascular Surgery
  Vanderbilt University Medical Center
  Vascular Surgery
  Nashville, Tennessee, United States

  Disclosure(s): BD (formerly Bard): Consultant
  Boston Scientific: Consultant
  Caeli Vascular: Consultant
  Cook Medical: Consultant
  Cordis: Consultant
  Deerfield EGLX Accelerator: Consultant
  Elastimed: Consultant
  Endologix: Consultant
  Inari Medical: Consultant
  LimFlow: Consultant
  Medtronic: Consultant
  NAMSA: Consultant
  Nectero: Consultant
  Penumbra: Consultant
  Pylon Medical: Consultant
  Shockwave: Consultant
  Vesteck: Consultant